Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-350
Closed -$55K 4175
2023
Q3
$55K Buy
+350
New +$78.4K 0.01% 1459
2019
Q3
Sell
-200
Closed -$23K 4566
2019
Q2
$23K Buy
+200
New +$20.5K ﹤0.01% 2107
2019
Q1
Sell
-1,600
Closed -$126K 4586
2018
Q4
$126K Buy
+1,600
New +$135K 0.01% 904
2017
Q4
Sell
-54
Closed -$2K 5696
2017
Q3
$2K Buy
+54
New +$2.95K ﹤0.01% 5136
2017
Q2
Sell
-957
Closed -$41K 6912
2017
Q1
$41K Sell
957
-1,821
-66% -$78.1K ﹤0.01% 2610
2016
Q4
$104K Buy
2,778
+2,486
+851% +$92.6K ﹤0.01% 1875
2016
Q3
$11K Sell
292
-1,100
-79% -$43.5K ﹤0.01% 4121
2016
Q2
$42K Buy
1,392
+1,000
+255% +$31.1K ﹤0.01% 2534
2016
Q1
$12K Buy
392
+299
+322% +$9.39K ﹤0.01% 3862
2015
Q4
$3K Buy
+93
New +$3.13K ﹤0.01% 5343

Other funds holding PODD

Cutler Group's PODD Position: Q4 2023 in Review

Cutler Group sold out of Insulet (PODD) in Q4 2023, closing a stake of 350 shares — an estimated $55K sold.

Cutler Group first reported a position in PODD in Q4 2015 and held it in 10 quarters. The position peaked at $126K in Q4 2018. 591 funds tracked by Wall St. Rank hold PODD as of Q4 2023.

  • Cutler Group reported no remaining Insulet position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 350 Insulet shares in Q4 2023, an estimated $55K.
  • Cutler Group first reported a position in Insulet in Q4 2015 and held it in 10 quarters.
  • Cutler Group's Insulet position peaked at $126K in Q4 2018.
  • 591 funds tracked by Wall St. Rank held Insulet as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.